Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Radius Health, Inc. (RDUS)
Sector: Healthcare; Industry: Drug Manufacturers—Specialty & Generic

Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine therapeutics in the areas of osteoporosis and oncology. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Eisai Co. Ltd.; Duke University; and Teijin Limited.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-01-06 BIOTECH TARGET N V 10%-Owner Buy 550,000 $6.31 $3,469,060 No
2021-12-16 Rubric Capital Management LP 10%-Owner Buy 146,685 $7.07 $1,037,752 No
2021-12-15 Rubric Capital Management LP 10%-Owner Buy 462,238 $6.90 $3,191,376 No
2021-12-10 Rubric Capital Management LP 10%-Owner Buy 1,593,506 $7.54 $12,015,792 No
2021-09-29 BIOTECH TARGET N V 10%-Owner Buy 100,000 $12.95 $1,294,500 No
2021-09-22 BIOTECH TARGET N V 10%-Owner Buy 150,000 $12.28 $1,841,280 No
2021-03-05 Chopas James George Principal Finance Accounting Sell 370 $20.88 $7,726 No
2021-02-25 Grausso Sal Chief Commercial Officer Sell 1,322 $18.93 $25,025 No
2020-11-05 BIOTECH TARGET N V 10%-Owner Buy 100,000 $14.26 $1,426,230 No
2020-09-14 BIOTECH TARGET N V 10%-Owner Buy 200,000 $11.69 $2,338,680 No
2020-09-11 BIOTECH TARGET N V 10%-Owner Buy 199,029 $11.33 $2,255,118 No
2020-07-08 BIOTECH TARGET N V 10%-Owner Buy 25,000 $13.21 $330,178 No
2020-04-30 BIOTECH TARGET N V 10%-Owner Buy 50,000 $15.75 $787,555 No
2020-02-26 Kelly Joseph Francis Sr. VP of Sales and Marketing Sell 889 $17.93 $15,942 No
2020-02-26 Hughes Owen Director Sell 2,750 $17.95 $49,362 No
2020-02-26 Morris Charles Q Chief Medical Officer Sell 1,256 $17.93 $22,524 No
2020-02-26 Rosenberg Anthony Director Sell 1,815 $17.95 $32,579 No
2020-02-26 Dere Willard H Director Sell 1,925 $17.95 $34,554 No
2020-02-26 Carmona Jose Chief Financial Officer Sell 1,292 $17.93 $23,169 No
2019-11-06 BIOTECH GROWTH N V 10%-Owner Buy 100,000 $23.00 $2,300,300 No
2019-07-01 Rosenberg Anthony Director Sell 1,584 $24.60 $38,966 No
2019-06-07 Kelly Joseph Francis Sr. VP of Sales and Marketing Buy 2,500 $21.81 $54,536 No
2019-05-10 Kelly Joseph Francis Sr. VP of Sales and Marketing Buy 2,000 $21.43 $42,860 No
2019-04-16 Hughes Owen Director Sell 2,400 $22.22 $53,328 No
2019-04-16 Graves Kurt Director Sell 4,800 $22.32 $107,136 No
2019-04-16 Dere Willard H Director Sell 1,680 $22.22 $37,330 No
2019-04-11 Roychowdhury Debasish Director Sell 4,800 $22.15 $106,320 No
2019-03-05 Hopfield Jessica Director Buy 12,800 $19.23 $246,190 No
2018-12-20 BIOTECH GROWTH N V 10%-Owner Buy 60,000 $14.48 $868,782 No
2018-12-17 Kelly Joseph Francis Sr. VP of Sales and Marketing Buy 3,000 $15.71 $47,130 No

Insider Smart

PENN NATIONAL GAMING INC (PENN) - PENN took a deep dive from $36 to $5 due to the crash, anyone who was bold enough to pick up some shares in March or April could have made a 900% profit in 2 months. But bottom fishing is always easier said than done, if one took a safer bet and followed multiple insider buying around $18, a 100% profit is still impressive.

Insider Smart

Ovintiv Inc (OVV) - Insiders of OVV have been HEAVILY accumulating shares in March with a sub-$3 cost. And the stock is now $11. An awesome 400% gain can't be missed if you found it was heavily accumulated earlier.